DIGOXIN
- Product NDC
- 0615-7935
- 11-digit product format
- 006157935
- Labeler code
- 0615
- Product ID
- 0615-7935_1e632ed8-c688-4617-bd91-298fc030b2c1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DIGOXIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- NDA020405
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2014-01-14
- Marketing end
- 0000-00-00
- Substance
- DIGOXIN
- Active strength
- 0 mg/1
- Pharmacologic classes
- Cardiac Glycoside [EPC],Cardiac Glycosides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-7935-14 | 2021-04-16 | C162847 | 48780-1 | 9d75b9cf-db17-f424-e053-dadaa90a57ce | b8dee4a1-e4e7-4bf3-b7da-de15d2373070 |
| 0615-7935-30 | 2021-04-16 | C162847 | 48780-1 | 9d75b9cf-db17-f424-e053-dadaa90a57ce | b8dee4a1-e4e7-4bf3-b7da-de15d2373070 |
| 0615-7935-39 | 2021-04-16 | C162847 | 48780-1 | 9d75b9cf-db17-f424-e053-dadaa90a57ce | b8dee4a1-e4e7-4bf3-b7da-de15d2373070 |
| 0615-7935-14 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-db17-f424-e053-dadaa90a57ce | b8dee4a1-e4e7-4bf3-b7da-de15d2373070 |
| 0615-7935-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-db17-f424-e053-dadaa90a57ce | b8dee4a1-e4e7-4bf3-b7da-de15d2373070 |
| 0615-7935-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-db17-f424-e053-dadaa90a57ce | b8dee4a1-e4e7-4bf3-b7da-de15d2373070 |